Home NEWS Eli Lilly to invest $1 billion on contract manufacturing in India

Eli Lilly to invest $1 billion on contract manufacturing in India

Eli Lilly to invest  billion on contract manufacturing in India

Eli Lilly to invest  billion on contract manufacturing in India

Telangana Chief Minister A. Revanth Reddy handing over a memento to Patrik Jonsson, executive V-P and president, Lilly International, Eli Lilly and Company in the presence of Industries and IT Minister D. Sridhar Babu.
| Photo Credit: Arrangement

Eli Lilly and Company will invest more than $1 billion over the next several years into new contract manufacturing in India. Additionally, the global pharma major will establish a new manufacturing and quality facility in Hyderabad.

The investment will further strengthen the manufacturing and supply capabilities to support the company’s evolving portfolio, Eli Lilly said on Monday (October 6, 2025). “We are making significant investments to increase manufacturing and medicine supply capacity around the world to help ensure patients have access to the medicines they need,” said Patrik Jonsson, executive vice president and president, Lilly International, Eli Lilly and Company.

The proposed investment reaffirms the Eli Lilly’s confidence in India as a hub for capability building within the company’s global network.

Working with trusted contract manufacturers expands the company’s capabilities to deliver life-changing medicines at greater scale, with quality always at the core, he said.

The company said the investment decision resonates with the Make in India agenda. Since 2020, Lilly has committed more than $55 billion to build, expand and acquire facilities in the U.S. and around the world. These facilities and investments address growth from potential new medicines to treat diabetes and obesity, Alzheimer’s disease, cancer and autoimmune conditions and prepare for medicines of the future. This initiative reflects Lilly’s intent to leverage India’s highly skilled talent pool to support its global manufacturing growth and deliver medicines to patients worldwide, it said in a release.

Hub in Hyderabad

On the the new manufacturing and quality facility in Hyderabad, a city where the company’s GCC opened in Augustit said the proposed facility will be a hub offering advanced technical capabilities and oversight for Lilly’s contract manufacturing network across India. Recruitment will begin immediately, with openings across roles such as engineers, chemists, analytical scientists, quality control and assurance professionals and management positions.

“Lilly’s continued expansion in Hyderabad highlights the city’s emergence as a powerhouse in global healthcare innovation. From the recent opening of its innovation and technology site to a new manufacturing collaboration and the establishment of a manufacturing and quality hub, Lilly is moving swiftly to expand its presence in Telangana. The decision reinforcing the State’s position as a preferred destination for cutting-edge healthcare investments,” Telangana Chief Minister A. Revanth Reddy said.

The company said it has a longstanding presence in India, which includes a commercial site in Gurugram and specialised sites in Bengaluru and Hyderabad that serve as important hubs supporting global innovation.

Industries and IT Minister D. Sridhar Babu said the company’s expansion in Hyderabad is a testament to Telangana’s dynamic industrial landscape and its growing influence in advanced healthcare manufacturing. The State’s focus on technology-driven infrastructure and ease of doing business continues to attract global leaders across sectors and lifesciences sector in particular has been on accelerated growth.”

Source link